Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
219 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3138 (93%)
3367
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
341 (93%)
Reversed:
0 (0%)
365
144 (4%)
68 (28%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-10-17 | 2017-12-15 | 26163 |
| APO-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-11-02 | 2017-12-31 | 27809 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2023-06-09 | 2023-10-15 | 194587 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-06-18 | 2021-07-21 | 141241 |
| APO-HYDROMORPHONE | 4MG | TABLET | Resolved | 2021-07-16 | 2021-07-24 | 142683 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-09-21 | 2021-10-25 | 145937 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-11-12 | 2021-12-20 | 149167 |
| APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154175 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-01-08 | 2021-03-01 | 131163 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-11-13 | 2020-04-04 | 98562 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-03 | 2020-04-04 | 71124 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-03 | 2020-04-04 | 71127 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-30 | 2020-04-04 | 74019 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-05 | 2020-04-04 | 77849 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-05 | 2020-04-04 | 77852 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-05 | 2020-04-04 | 77855 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-05 | 2020-04-04 | 77858 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-03-20 | 2020-04-04 | 79039 |
| APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2024-05-24 | 2024-06-14 | 228780 |
| APO-HYDROXYQUINE | 200MG | TABLET | Resolved | 2024-07-18 | 2024-09-20 | 233330 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |